The report from ASFA COVID-19 taskforce: Considerations and prioritization on apheresis procedures during the SARS-CoV-2 coronavirus disease (COVID-19) pandemic.

Authors:
Yamada C; Hofmann JC; Witt V; Gupta GK; Winters JL and 1 more

Journal:
J Clin Apher

Publication Year: 2021

DOI:
10.1002/jca.21939

PMCID:
PMC8646674

PMID:
34510542

View on PubMed View on PMC View Publisher
Journal Information

Full Title: J Clin Apher

Abbreviation: J Clin Apher

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Hematology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Addition of plerixafor in poorly mobilized allogeneic stem cell donors.
Zhuang L; Lauro D; Wang S and 1 more (2022) - Transparency Score: 2/6
Assessing efficacy and safety of replacement fluids in therapeutic plasma exchange: A systematic sc…
Kohli R; Geneen LJ; Brunskill SJ and 7 more (2022) - Transparency Score: 4/6
Comparison of procedure times and collection efficiencies using integrated and multistep nonintegra…
Mayer W; Kontekakis A; Maas C and 3 more (2022) - Transparency Score: 3/6
Distinguishing and overlapping laboratory results of thrombotic microangiopathies in HIV infection:…
Louw S; Jacobson BF; Mayne ES. (2022) - Transparency Score: 3/6
The safety and performance of the Spectra Optia apheresis system platelet depletion protocol in pat…
Lopert P; Abdelrahman S; Graybill CA and 11 more (2022) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
1/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"CONFLICT OF INTEREST The authors declare no conflict of interest."

Funding Disclosure
Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025